Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1711results about "Monoazo dyes" patented technology

Synthetic glucopyranosyl lipid adjuvants

Compounds, particularly, glucopyranosyl lipid adjuvant (GLA) compounds, having the following structure (I) are provided:or a pharmaceutically acceptable salt thereof, wherein L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, Y1, Y2, Y3, Y4, R1, R2, R3, R4, R5, R6, are as defined herein. Pharmaceutical compositions, vaccine compositions, and related methods for inducing or enhancing immune responses, are also provided.
Owner:ACCESS TO ADVANCED HEALTH INST

Ureter detection using waveband-selective imaging

Selective reflection of light by ureters and by tissue around the ureters is used to safely and efficiently image the ureters. In one aspect, a plurality of surgical site scenes is captured. Each of the plurality of surgical site scenes is captured from reflected light having a different light spectrum. The plurality of captured surgical site scenes is analyzed to identify ureter tissue in the captured surgical site scenes. A surgical site scene is displayed on a display device. The displayed surgical site scene has ureter tissue artificially highlighted.
Owner:INTUITIVE SURGICAL OPERATIONS INC

Ink, ink jet recording method and azo compound

An ink containing at least one dye represented by formula (1): wherein R1, R2 and R3 are each independently a hydrogen atom or a monovalent group; Z is a nitrogen atom, or a carbon atom to which a hydrogen atom or a monovalent group is bonded; and at least one of R1, R2, R3, and the monovalent group that Z has is a substituent having a heterocyclic group substituted with an azo group.
Owner:FUJIFILM CORP

Multi-Compartment Pouch

The present relates to a multi-compartment pouch suitable for use in a laundry application comprising a water-soluble film and having at least a first and a second compartment, wherein each compartment comprises a composition, characterised in that the second compartment comprises a whitening agent that exhibits a hueing efficiency of at least 5 and a wash removal value in the range of from about 30% to about 95%.
Owner:THE PROCTER & GAMBLE COMPANY

Ink, ink set, ink jet recording method, ink cartridge and ink jet recording apparatus

ActiveUS20060192827A1High color developabilityGood ink ejection stabilityMonoazo dyesMeasurement apparatus componentsThermal energyHigh color
An ink to be used in an ink jet recording method of ejecting an ink from a recording head through action of thermal energy can improve the ink ejection stability and shows a high storage stability and a high color developability. An ink to be used in an ink jet recording method of ejecting an ink from a recording head through action of thermal energy is characterized in that the ink comprises a pigment represented by the general formula (1), a dispersant, a water-soluble organic compound and an aggregation inhibiting substance for inhibiting aggregation after dispersion breakdown of the pigment, and the content (mass %) of the aggregation inhibiting substance with respect to the total mass of ink is 0.4 times or more to less than 1.3 times of the content (mass %) of the pigment with respect to the total mass of ink.
Owner:CANON KK

Shading compositions

InactiveUS7909890B2Monoazo dyesPhthalocyanine-azo dyesPolymer sciencePhthalocyanine
The present invention relates to new compositions comprising compounds, which are molecular combinations of a phthalocyanine and a mono-azo dyestuff linked via specific linking groups. Further aspects are an improved shading process for textile materials and also use of these shading compositions for shading textiles.
Owner:PROCTER & GAMBLE CO

Preparation of high nitrogen compound and materials therefrom

The high-nitrogen compound of the formulawas prepared. Pyrolysis of the compound yields carbon nitrides C2N3 and C3N5. The carbon nitrides vary in their density, texture, and morphology.
Owner:LOS ALAMOS NATIONAL SECURITY

Method for preparing light-absorbing polymeric compositions

The present invention recites a method comprising reacting in a solvent in the presence of a basea) at least one diacidic monomer comprising about 1 to 100 mole % of at least one light-absorbing monomer having a light absorption maximum between about 300 nm and about 1200 nm and 99-0 mole % of a non-light absorbing monomer which does not absorb significant light at wavelengths above 300 nm or has a light absorption maximum below 300 nm, withb) an organic compound of Formula IIwherein B is a divalent organic radical to form a light absorbing composition comprising a mixture of a polymer having the formulaand a cyclic compound having the general formulawherein B is as defined above; n is at least 2, m is 1, 2, 3 or 4 and A comprises the residue of a diacidic monomer comprising about 1 to 100 mole % of at least one light-absorbing monomer having a light absorption maximum between about 300 nm and about 1000 nm and wherein the remaining portion of A comprises the residue of a non-light absorbing monomer which does not absorb significant light at wavelengths above 300 nm or has a light absorption maximum below 300 nm.
Owner:EASTMAN CHEM CO

Phthalimide derivatives of non-steroidal Anti-inflammatory compounds and/or tnf-alpha modulators, method for producing same, pharmaceutical compositions containing same and uses thereof for the treatment of inflammatory diseases

InactiveUS20120115817A1Inhibit inflammationMinimizing major limitation and complicationBiocideMonoazo dyesNon steroidal anti inflammatoryRheumatoid arthritis
The present invention relates to phthalimide derivatives of non-steroidal and / or TNF-α modulating anti-inflammatory compounds as well as the process of obtaining the so-called derivatives, pharmaceutical compositions containing such derivatives and their uses, including use in the treatment of inflammatory diseases, especially those related to chronic inflammatory processes, such as rheumatoid arthritis and intestinal inflammatory diseases (for instance, Chron's disease) and the use of the referred to pharmaceutical compositions as antipyretic, analgesic and platelet antiaggregating medications.
Owner:EMS +1

Colored curable composition, color filter and method of producing thereof

A dye polymer prepared by polymerizing one or more pigment monomer represented by formula (I), or a dye polymer prepared by copolymerizing one or more pigment monomer represented by formula (I) and one or more monomer having one ethylene group. [R1: H, chlorine atom, alkyl group, or aryl group; L1: —N(R2)C(═O)—, —OC(═O)—, —C(═O)N(R2)—, —C(═O)O—, or a group represented by formula (II), formula (III), or formula (IV); R2: H, alkyl group, aryl group, or hetero cyclic group; L2: divalent coupler for coupling L1 and Dye; n=0 or 1, m=0 or 1; Dye: pigment residue]
Owner:FUJIFILM CORP

Laundry treatment compositions

A laundry treatment composition which comprises a surfactant and from 0.0001 to 0.1 wt % of a combination of dyes which together have a visual effect on the human eye as a single dye having a peak absorption wavelength on cotton of from 540 nm to 650 nm, preferably from 570 mn to 630 mn, the combination comprising a photostable dye which is substantive to cotton.
Owner:CONOPCO INC D B A UNILEVER

Yellow toner

Provided is a yellow toner having toner particles each containing at least a binder resin, a colorant, and a polar resin, the yellow toner being characterized in that: the colorant is a coloring compound having a specific structure; in a microscopic compression test at a measurement temperature of 25° C., the toner has a recovery ratio Z(25) of 40 to 80%; and the toner has a glass transition temperature (TgA) measured with a differential scanning calorimeter (DSC) of 40° C. to 60° C. and a temperature (P1) of the highest endothermic peak measured with the DSC of 70° C. to 90° C., and the temperature (P1) of the highest endothermic peak and the glass transition temperature (TgA) satisfy the relationship of 15° C.≦P1−TgA≦50° C.
Owner:CANON KK

Dark quenchers for donor-acceptor energy transfer

The present invention provides a family of dark quenchers, termed Black Hole Quenchers (“BHQs”), that are efficient quenchers of excited state energy but which are themselves substantially non-fluorescent. Also provided are methods of using the BHQs, probes incorporating the BHQs and methods of using the probes.
Owner:HSBC TRUSTEE COMPANY UK LIMITED AS SECURITY AGENT

Coloring composition for image formation and method for improving ozone resistance of color image

A coloring composition for image formation comprising an azo dye having an aromatic nitrogen-containing 6-membered heterocyclic ring as a coupling component, a coloring composition which comprises an azo compound having an oxidation potential nobler than 1.0 V vs. SCE and comprising at least two substituents having a pKa value of −10 to 5 in water, and a method for improving ozone resistance of a color image, the method comprising using a compound having an oxidation potential nobler than 1.0 V vs. SCE and showing a maximum absorption at a wavelength between 500 nm and 580 nm with a half-value width of 150 nm or narrower.
Owner:FUJIFILM CORP

Coloring Matter, Ink, Ink, for Ink Jet, Ink Jet Recording Method, Color Toner, and Color Filter

ActiveUS20080274283A1Good storage stabilitySufficient fastness propertyMonoazo dyesDisazo dyesColor gelHue
[Problem] To provide a coloring matter which has a good hue, and is capable of forming an image high in fastness property under various use conditions and environmental conditions, and particularly suitable for an ink.[Solving Means] A coloring matter represented by the following formula (I):wherein in the formula, G represents a heterocyclic group, and n represents an integer of 1 to 3; when n is 1, R, X, Y, Z, Q, and G each represents a monovalent group; when n is 2, R, X, Y, Z, Q, and G each represents a monovalent or divalent substituent, provided that at least one represents a divalent substituent; and when n is 3, R, X, Y, Z, Q, and G each represents a monovalent, divalent or trivalent substituent, provided that at least two each represents a divalent substituent, or at least one represents a trivalent substituent.
Owner:FUJIFILM CORP

Yellow dyes for ink jet inks

InactiveUS7125446B2Excellent toneDesirable hueMonoazo dyesInksSolubilityHydrogen
This invention relates to a yellow ink composition for ink jet printing comprising a dye represented by Formula I, water and a humectant:wherein:R1 and R5 independently are hydrogen or a substituted or unsubstituted alkyl, aromatic or heterocyclic group;R2 and R4 independently are hydrogen or a non-metallic substituent;R3 is hydrogen or a substituted or unsubstituted alkyl, acyl, sulfonyl, aromatic or heterocyclic group;and X is an electron withdrawing group;with the proviso at least one of R1, R2, R3, R4 and R5 comprises a group capable of imparting water solubility to the dye.
Owner:EASTMAN KODAK CO

Ink set

To provide an ink set capable of recording images with good ozone fastness on a recording medium, an ink set of the present invention comprises at least a yellow ink composition, a magenta ink composition, and a cyan ink composition. The cyan ink composition contains at least one of the compounds expressed by formula (1) below as a cyan dye: and the magenta ink composition contains, as a colorant, at least one substance selected from the group consisting of compounds expressed by formula (2) below: and salts thereof (in formula (2), A represents an alkylene group, an alkylene group containing a phenylene group, or a group expressed by formula (3) below: and X represents a group selected from the group consisting of NH2, OH, and Cl).
Owner:SEIKO EPSON CORP

Synthetic glucopyranosyl lipid adjuvants

Compounds, particularly, glucopyranosyl lipid adjuvant (GLA) compounds, having the following structure (I) are provided:or a pharmaceutically acceptable salt thereof, wherein L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, Y1, Y2, Y3, Y4, R1, R2, R3, R4, R5, R6, are as defined herein. Pharmaceutical compositions, vaccine compositions, and related methods for inducing or enhancing immune responses, are also provided.
Owner:ACCESS TO ADVANCED HEALTH INST

Non-fluorescent quencher compounds and biomolecular assays

Bis-diazo,triaryl and aryldiazo-N-arylphenazonium quencher moieties, substituted with electron-withdrawing and electron-donating substituents which induce polarity in the delocalized aryl / diazo ring systems, are useful as labels when attached to biomolecules such as polynucleotides, nucleosides, nucleotides, and polypeptides. The quencher moieties are non-fluorescent and accept energy from fluorescent reporter labels by any energy-transfer mechanism, such as FRET. Fluorescence quencher compositions are useful in preparing quencher labelled biomolecules for various molecular biology assays based on fluorescence detection.
Owner:APPL BIOSYSTEMS INC

Coloring compound and yellow toner containing the coloring compound

Provided are a coloring compound for color toner which satisfies all of solubility in an organic solvent, a color tone, and lightfastness, and does not inhibit the polymerization of a polymerizable monomer when used in a polymerized toner, and a yellow toner using the coloring compound and achieving compatibility between a good color tone and excellent lightfastness, in which, the coloring compound has a structure represented by the following formula (1).
Owner:CANON KK

Ink, ink set, ink jet recording method, ink cartridge and ink jet recording apparatus

An ink to be used in an ink jet recording method of ejecting an ink from a recording head through action of thermal energy can improve the ink ejection stability and shows a high storage stability and a high color developability. An ink to be used in an ink jet recording method of ejecting an ink from a recording head through action of thermal energy is characterized in that the ink comprises a pigment represented by the general formula (1), a dispersant, a water-soluble organic compound and an aggregation inhibiting substance for inhibiting aggregation after dispersion breakdown of the pigment, and the content (mass %) of the aggregation inhibiting substance with respect to the total mass of ink is 0.4 times or more to less than 1.3 times of the content (mass %) of the pigment with respect to the total mass of ink
Owner:CANON KK

Fluorescence quenching azo dyes, their methods of preparation and use

Disclosed is a group of azo quencher compositions useful as fluorescence quenchers having the general structure of formula 1, methods of making or using the compositions, and kits comprising the composition.
Owner:INTEGRATED DNA TECHNOLOGIES

Process for synthesizing azo dispersion dyes monomer compound

The invention provides the synthesis process of an azo-disperse dyes monomeric compound, comprising the following steps: (1) diazotization of compound (II) and nitrosyl sulfuric acid is completed with the temperature being controlled between 1 DEG C and 25 DEG C; (2) water, emulsifying agent and compound (III) are added into a coupling reactor and stirring and pulping are completed at the temperature ranging from 10 DEG C to 25 DEG C; (3) diazonium salt is evenly added into the coupling reactor from below the slurry and is stirred till the end of the reaction, and then extraction filtration and washing are adopted till the slurry shows neutrality; finally, the azo-disperse dyes monomeric compound can be obtained after drying. Through improving preparation process, a great amount of ice or frozen salt water no longer needs to be added for cooling down during coupling reaction to meet the requirements; the temperature of coupling reaction is gradually raised to 20 DEG C to 45 DEG C by use of heat liberation of coupling reaction and diazonium salt dilution instead; thereby, under the condition of identical quality effect, cost is greatly reduced and at the same time, energy consumption during preparing cooling agent such as ice and frozen salt water is also substantially reduced.
Owner:SHANGYU JINGUAN CHEM IND +2

Compounds and methods for labeling oligonucleotides

The invention provides a novel method of labeling oligonucleotides, with reporter moieties, including but not limited to, quenchers, fluorophores, biotin, digoxigenin, peptides and proteins. In addition, this invention provides a method of detecting hybridization of oligonucleotides. This invention also provides novel azo quenchers having the general formula shown below.The invention further provides compositions comprising labeled oligonucleotides and solid supports. The invention also provides kits comprising at least one composition of the present invention.
Owner:INTEGRATED DNA TECHNOLOGIES

Chemical Reporters of Protein Acylation

Methods and kits for detecting acylated proteins produced by cells that have been cultured or by cells within an organism are provided. Also provided are methods and kits for detecting acylated proteins produced by cells where affinity purification tags are that facilitate detection are used. Compounds useful for the detection of acylated proteins are also provided.
Owner:THE ROCKEFELLER UNIV

Ink, recording method, recording unit, ink cartridge, ink set, and recording apparatus

Magenta ink exhibiting excellent coloration on various recording materials is provided according to the present invention. The magenta ink can realize high image densities and can produce images having superior light resistance. The magenta ink contains first and second coloring materials represented by the following general formulae 1 and 2, respectively, and a water-based medium
Owner:CANON KK

Pyrazole compounds

InactiveUS20030060453A1Useful in treatmentBiocideMonoazo dyesLymphoproliferative diseaseAngiogenesis growth factor
Pharmaceutical compositions and compounds are provided. The compounds of the invention demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.
Owner:DERMIRA CANADA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products